Skip to main navigation Skip to search Skip to main content

Multicenter comparison of tacrolimus (FK) 506 whole blood concentrations as measured by the abbott imx analyzer and enzyme immunoassay with methylene chloride extraction

  • SUNY Buffalo
  • Fujisawa Pharmaceutical Company

Research output: Contribution to journalArticlepeer-review

18 Scopus citations

Abstract

A multicenter comparison was made between the Abbott IMX and enzyme-linked immunosorbent assay (ELISA) procedures for analysis of tacrolimus (FK 506) in whole blood. Proficiency samples and 853 patient specimens obtained after various organ transplantations were assayed by 13 laboratories. Both groups of test samples yielded slightly lower (7 and 13) values by the IMX method, but the difference is not clinically meaningful. The type of organ transplant was not a factor that contributed to assay variation. The Abbott IMX results were essentially equivalent to ELISA and considerably facilitates monitoring of FK 506 therapy.

Original languageEnglish
Pages (from-to)287-292
Number of pages6
JournalTherapeutic Drug Monitoring
Volume16
Issue number3
DOIs
StatePublished - Jun 1994

Keywords

  • Enzyme immunoassay
  • Enzyme-linked immunosorbent assay
  • Fk506
  • Im assay
  • Tacrolimus
  • Therapeutic monitoring

Fingerprint

Dive into the research topics of 'Multicenter comparison of tacrolimus (FK) 506 whole blood concentrations as measured by the abbott imx analyzer and enzyme immunoassay with methylene chloride extraction'. Together they form a unique fingerprint.

Cite this